The global microfluidic immunoassay market is expected to reach $1.59 billion by 2031, according to a new report by Meticulous Research®, growing at a CAGR of 7.3% between 2024 and 2031.
In recent years, the clinical diagnostics field has witnessed a rising demand for real-time detection technologies, driven by the growing prevalence of chronic and infectious diseases. This surge is...